Prices as of 2026/10/30 close
Company comparison · Pharmaceutical & Medical Distribution
Alfresa is the bigger company, with revenue of ¥3.1T — 4.3x Ship Healthcare's ¥718.2B.
Ship Healthcare earns more on each yen of sales, with an operating margin of 3.4% — 2.2 points above Alfresa (1.2%).
Revenue growth in the latest results: Ship Healthcare +5.9%, Alfresa +4.8%. For next year, Ship Healthcare guides for the fastest operating profit growth (+6.2%).
Over the past year the shares moved Alfresa +16.4%, Ship Healthcare +11.5%.
Head-to-head wins12 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Alfresa aheadAlfresa 3 : Ship Healthcare 0
Revenue: Alfresa ¥3.1T / Ship Healthcare ¥718.2B
ProfitabilityInvestors
Ship Healthcare aheadAlfresa 0 : Ship Healthcare 2
Operating margin: Alfresa 1.2% / Ship Healthcare 3.4%
GrowthInvestors
Ship Healthcare aheadAlfresa 0 : Ship Healthcare 4
Revenue growth (YoY): Alfresa +4.8% / Ship Healthcare +5.9%
Stock & balance sheetInvestors
Alfresa aheadAlfresa 2 : Ship Healthcare 0
Share price, 1 year: Alfresa +16.4% / Ship Healthcare +11.5%
Pay & workforceJob seekers
Alfresa aheadAlfresa 1 : Ship Healthcare 0
Average tenure: Alfresa 14.0 yrs / Ship Healthcare 9.3 yrs
| Metric | Alfresa | Ship Healthcare | Gap |
|---|---|---|---|
| Revenue | ◎¥3.1T | ¥718.2B | 4.3x |
| Operating profit | ◎¥36.2B | ¥24.5B | 1.5x |
| Net income | ◎¥41.7B | ¥13.4B | 3.1x |
| Metric | Alfresa | Ship Healthcare | Gap |
|---|---|---|---|
| Operating margin | 1.2% | ◎3.4% | 2.2pt |
| Net margin | 1.3% | ◎1.9% | 0.5pt |
| ROE | 8.4% | — | |
| Revenue per employee | ¥46.3B | — |
| Metric | Alfresa | Ship Healthcare | Gap |
|---|---|---|---|
| Revenue growth (YoY) | +4.8% | ◎+5.9% | 1.1pt |
| Operating profit growth (YoY) | −5.0% | ◎−1.2% | 3.8pt |
| Revenue CAGR | — | +7.6% | |
| Guidance: revenue growthnext FY plan | +1.3% | ◎+3.0% | 1.8pt |
| Guidance: op. profit growthnext FY plan | −6.3% | ◎+6.2% | 12.5pt |
| Metric | Alfresa | Ship Healthcare | Gap |
|---|---|---|---|
| Share price, 1 year | ◎+16.4% | +11.5% | 4.9pt |
| Share price, 3 months | ◎+3.4% | −2.0% | 5.5pt |
| P/E (trailing)lower = cheaper | 10.8x | — | |
| Equity ratio | 33.7% | — | |
| Share price (close) | ¥2,469 | ¥2,531.5 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Alfresa | Ship Healthcare | Gap |
|---|---|---|---|
| Average salary | ¥8.39M | — | |
| Average tenure | ◎14.0 yrs | 9.3 yrs | 4.7 |
| Average age | 46.6 | 42.9 | 3.7 |
| Employees | 67 | 22 | 3.0x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥2,469+16.4% (1Y)
Alfresa +16.4% over 1Y. Compared: Ship Healthcare +11.5%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Alfresa4 segments
Ship Healthcare4 segments
ARevenue in the latest results: Alfresa ¥3.1T, Ship Healthcare ¥718.2B. Alfresa is the bigger company, with revenue of ¥3.1T — 4.3x Ship Healthcare's ¥718.2B.
AOperating margins: Ship Healthcare 3.4%, Alfresa 1.2%. Ship Healthcare turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Alfresa +16.4%, Ship Healthcare +11.5%. Alfresa has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
